Currently out of the existing stock ratings of Nathan Treybeck, 28 are a BUY (53.85%), 24 are a HOLD (46.15%).
Analyst Nathan Treybeck, currently employed at WELLS FARGO, has had 63.85% of price targets met with an average potential upside of 15.1%, reached in 124 days on average.
Nathan Treybeck has documented 102 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IRTC, iRhythm Technologies at 06-Nov-2026.
Analyst best performing recommendations are on NVRO (NEVRO CORP).
The best stock recommendation documented was for NVRO (NEVRO CORP) on 8/7/2024. The price target of $5.5 was fulfilled within 1 day with a profit of $0.67 (13.87%), with a performance score of 138.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Aug-2023
$140
$48.09 (52.32%)
$168
9 days ago
(09-Nov-2026)
13/21 (61.9%)
$51.27 (57.78%)
195
Buy Since 22-Aug-2024
$124
$32.09 (34.91%)
$157
12 days ago
(06-Nov-2026)
33/39 (84.62%)
$-6.19 (-4.75%)
187
Buy Since 06-Apr-2026
$140
$48.09 (52.32%)
$165
12 days ago
(06-Nov-2026)
2/8 (25%)
$9.81 (7.54%)
34
Buy Since 06-May-2022
$165
$73.09 (79.52%)
$194
12 days ago
(06-Nov-2026)
14/21 (66.67%)
$34.81 (26.74%)
330
Buy Since 24-Jun-2022
$170
$78.09 (84.96%)
$185
12 days ago
(06-Nov-2026)
8/14 (57.14%)
$39.81 (30.58%)
552
Which stock is Nathan Treybeck most bullish on?
Which stock is Nathan Treybeck most reserved on?
What Year was the first public recommendation made by Nathan Treybeck?